Somatuline Depot Interactions
There are 164 drugs known to interact with Somatuline Depot (lanreotide), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 4 are major, 148 are moderate, and 12 are minor.
- View all 164 medications that may interact with Somatuline Depot
- View Somatuline Depot alcohol/food interactions (1)
- View Somatuline Depot disease interactions (7)
Most frequently checked interactions
View interaction reports for Somatuline Depot (lanreotide) and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- amlodipine
- Ativan (lorazepam)
- atorvastatin
- benzonatate
- Byetta (exenatide)
- cabergoline
- Celebrex (celecoxib)
- Concerta (methylphenidate)
- Creon (pancrelipase)
- Cymbalta (duloxetine)
- dronabinol
- Entresto (sacubitril / valsartan)
- Humalog (insulin lispro)
- hydrochlorothiazide
- ibuprofen
- Lamictal (lamotrigine)
- Levemir (insulin detemir)
- Lipitor (atorvastatin)
- lisinopril
- Lunesta (eszopiclone)
- metformin
- metoprolol
- omeprazole
- Prilosec (omeprazole)
- Synthroid (levothyroxine)
- testosterone
- Topamax (topiramate)
- tramadol
- Vitamin D3 (cholecalciferol)
Somatuline Depot alcohol/food interactions
There is 1 alcohol/food interaction with Somatuline Depot (lanreotide).
Somatuline Depot disease interactions
There are 7 disease interactions with Somatuline Depot (lanreotide) which include:
- hepatic impairment
- renal impairment
- thyroid abnormalities
- adrenal insufficiency
- bradycardia
- cholelithiasis
- diabetes
Report options
More about Somatuline Depot (lanreotide)
- Somatuline Depot consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: somatostatin and somatostatin analogs
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Cabometyx
Cabometyx is used to treat advanced kidney cancer, liver cancer, thyroid cancer, and pancreatic and ...
Sandostatin
Sandostatin is used to treat acromegaly and to reduce flushing episodes and watery diarrhea caused ...
Lutathera
Lutathera is a targeted radiotherapy used for gastroenteropancreatic neuroendocrine tumors ...
Afinitor
Afinitor prevents the growth of cancer cells and is used to treat advanced kidney cancer. Learn ...
Sandostatin LAR Depot
Sandostatin LAR Depot is used for acromegaly, carcinoid tumor, vasoactive intestinal peptide tumor
Cabozantinib
Cabozantinib systemic is used for hepatocellular carcinoma, neuroendocrine tumors, renal cell ...
Bromocriptine
Bromocriptine systemic is used for acromegaly, hyperprolactinemia, parkinson's disease, tardive ...
Everolimus
Everolimus (Afinitor, Afinitor Disperz, Zortress) belongs to a class of drugs called kinase ...
Octreotide
Octreotide systemic is used for acromegaly, carcinoid tumor, diabetes, type 1, diarrhea, dumping ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
